Ignite Creation Date:
2024-05-06 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05205200
Status:
RECRUITING
Last Update Posted:
2024-02-08
First Post:
2022-01-11
Brief Title:
Immune Therapy in HR-positiveHER2-negative Metastatic Breast CancerENIGMA-BCTOP-L-M02
Sponsor:
Organization:
Fudan University